Author name: Michelle Jones

COVID-19, Evusheld, and Liver Patients

Evusheld is a long-acting investigational protective measure against COVID-19, featuring a combination of two monoclonal antibodies. The FDA recently gave its approval under an emergency use authorization (EUA). Evusheld is a game-changer for liver patients and other individuals with a compromised immune system. What is Evusheld, and Who Can Use It? Evusheld is a combination […]

COVID-19, Evusheld, and Liver Patients Read More »

The liver and alcohol

The Effects of Alcohol on the Liver

Alcohol is one of the most widely used substances among America’s adult and teen populations, posing substantial health and safety risks. Even though most know the adverse effects of alcohol, many tend to do so without fully recognizing the health risks of consuming alcohol excessively. The liver is one of the essential organs in the

The Effects of Alcohol on the Liver Read More »

Increasing diversity in liver research

Why Minority Participation in Liver Research Matters

April is National Minority Health Month (NMHM), a time to raise awareness about health disparities that affect people from racial and ethnic minority groups. Liver disease is growing in prevalence in the Hispanic population. It is also a leading cause of death in the U.S. Through education, we can lower the risk. Through participation, we

Why Minority Participation in Liver Research Matters Read More »

Scroll to Top